Sandoz Desloratadine

Desloratadine is a non-sedating antihistamine medication marketed under various brand names, with Sandoz being one of the leading generic manufacturers. Sandoz was originally founded in Switzerland and became a legendary name in the pharmaceutical industry, particularly known for its focus on generic medicines and biosimilars. In 1996, Sandoz merged with Ciba-Geigy to form Novartis, which remained its parent company for decades.

In a landmark transition completed in late 2023, Sandoz was successfully spun off from Novartis to become a fully independent, standalone public company. Today, Sandoz is headquartered in Basel, Switzerland, and operates as a global leader in generic and biosimilar medicines. While the company is Swiss, its manufacturing network is global, utilizing facilities across Europe and other regions to supply international markets.